231 related articles for article (PubMed ID: 21819332)
1. Progress and challenges in the discovery of macrofilaricidal drugs.
Geary TG; Mackenzie CD
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):681-95. PubMed ID: 21819332
[TBL] [Abstract][Full Text] [Related]
2. Flubendazole as a macrofilaricide: History and background.
Geary TG; Mackenzie CD; Silber SA
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006436. PubMed ID: 30650160
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for the treatment of onchocerciasis and other filarial infections.
Hoerauf A; Adjei O; Büttner DW
Curr Opin Investig Drugs; 2002 Apr; 3(4):533-7. PubMed ID: 12090719
[TBL] [Abstract][Full Text] [Related]
4. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.
Hoerauf A
Curr Opin Infect Dis; 2008 Dec; 21(6):673-81. PubMed ID: 18978537
[TBL] [Abstract][Full Text] [Related]
5. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
6. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
Mackenzie CD; Geary TG
Expert Rev Anti Infect Ther; 2011 May; 9(5):497-501. PubMed ID: 21609260
[No Abstract] [Full Text] [Related]
7. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.
Hoerauf A; Mand S; Fischer K; Kruppa T; Marfo-Debrekyei Y; Debrah AY; Pfarr KM; Adjei O; Büttner DW
Med Microbiol Immunol; 2003 Nov; 192(4):211-6. PubMed ID: 12684759
[TBL] [Abstract][Full Text] [Related]
8. Current practices in the management of lymphatic filariasis.
Bockarie MJ; Taylor MJ; Gyapong JO
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):595-605. PubMed ID: 19485799
[TBL] [Abstract][Full Text] [Related]
9. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
Halliday A; Guimaraes AF; Tyrer HE; Metuge HM; Patrick CN; Arnaud KO; Kwenti TD; Forsbrook G; Steven A; Cook D; Enyong P; Wanji S; Taylor MJ; Turner JD
Parasit Vectors; 2014 Oct; 7():472. PubMed ID: 25338621
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic filariasis and onchocerciasis.
Taylor MJ; Hoerauf A; Bockarie M
Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
[TBL] [Abstract][Full Text] [Related]
11. Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis.
Jacobs RT; Lunde CS; Freund YR; Hernandez V; Li X; Xia Y; Carter DS; Berry PW; Halladay J; Rock F; Stefanakis R; Easom E; Plattner JJ; Ford L; Johnston KL; Cook DAN; Clare R; Cassidy A; Myhill L; Tyrer H; Gamble J; Guimaraes AF; Steven A; Lenz F; Ehrens A; Frohberger SJ; Koschel M; Hoerauf A; Hübner MP; McNamara CW; Bakowski MA; Turner JD; Taylor MJ; Ward SA
J Med Chem; 2019 Mar; 62(5):2521-2540. PubMed ID: 30730745
[TBL] [Abstract][Full Text] [Related]
12. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro.
Hübner MP; Martin C; Specht S; Koschel M; Dubben B; Frohberger SJ; Ehrens A; Fendler M; Struever D; Mitre E; Vallarino-Lhermitte N; Gokool S; Lustigman S; Schneider M; Townson S; Hoerauf A; Scandale I
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008427. PubMed ID: 32628671
[TBL] [Abstract][Full Text] [Related]
13. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA
Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958
[TBL] [Abstract][Full Text] [Related]
14. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
[TBL] [Abstract][Full Text] [Related]
15. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
[TBL] [Abstract][Full Text] [Related]
16. Anti-Wolbachia treatment for lymphatic filariasis.
Stolk WA; de Vlas SJ; Habbema JD
Lancet; 2005 Jun 18-24; 365(9477):2067-8. PubMed ID: 15964428
[No Abstract] [Full Text] [Related]
17. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
19. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
20. Preclinical development of an oral anti-
Taylor MJ; von Geldern TW; Ford L; Hübner MP; Marsh K; Johnston KL; Sjoberg HT; Specht S; Pionnier N; Tyrer HE; Clare RH; Cook DAN; Murphy E; Steven A; Archer J; Bloemker D; Lenz F; Koschel M; Ehrens A; Metuge HM; Chunda VC; Ndongmo Chounna PW; Njouendou AJ; Fombad FF; Carr R; Morton HE; Aljayyoussi G; Hoerauf A; Wanji S; Kempf DJ; Turner JD; Ward SA
Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
